Akari Therapeutics PLC Cash Flow Reinvestment Rate
Latest as of March 2019:
0.00x
Akari Therapeutics PLC cash flow reinvestment rate. Akari Therapeutics PLC (AKTX) has a Cash Flow Reinvestment Rate of 0.00x as of March 2019, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $228.94K. Explore how well can Akari Therapeutics PLC service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$228.94K
USD
Capital Expenditures
$0.00
USD
Akari Therapeutics PLC Cash Flow Reinvestment Rate by Year (None–None)
Akari Therapeutics PLC cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Akari Therapeutics PLC. For the full cash flow conversion analysis, see Akari Therapeutics PLC operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow